Single-Cell Tests Predict Mycobacterial Infection Outcomes
A new study demonstrates that single‑cell transcriptional profiling can accurately predict outcomes of mycobacterial infections, distinguishing patients who will progress to active disease from those who remain latent. Researchers analyzed thousands of individual immune cells from blood samples, identifying distinct macrophage and T‑cell signatures linked to disease trajectory. The assay delivers results within days, a dramatic speedup over traditional culture‑based diagnostics. Validation across multiple cohorts suggests the test could become a frontline tool for tuberculosis management.
MTHFD2: Key to DNA Repair and LUAD Resistance
Researchers have identified the mitochondrial enzyme MTHFD2 as a pivotal driver of DNA repair mechanisms that enable lung adenocarcinoma (LUAD) cells to survive chemotherapy and targeted therapies. Experimental knockdown of MTHFD2 reduces homologous recombination efficiency and sensitizes tumors to platinum‑based...
System Can Diagnose Infections in 20 Minutes, Aiding Fight Against Drug Resistance
Researchers from the UK and China unveiled AutoEnricher, a microfluidic‑Raman platform that identifies bacterial and fungal pathogens in just 20 minutes. Validated on 305 patient samples, the system achieved 95 % accuracy and could detect mixed infections missed by conventional cultures....
The Benefits of an Immune-Directed ADC Strategy
Lifordi Immunotherapeutics is pursuing an immune‑directed antibody‑drug conjugate (ADC) strategy that uses the VISTA protein to deliver potent steroids directly to immune cells. VISTA’s rapid internalization allows the ADC to release its payload intracellularly, aiming to avoid the systemic toxicities...
Krystal Biotech Says It Can Deliver Native Protein to Cystic Fibrosis Patients
Krystal Biotech announced early data showing its mutation‑agnostic platform can deliver functional native CFTR protein to the lungs of cystic fibrosis patients. In pre‑clinical models, the therapy restored up to 45% of normal chloride transport and reduced inflammatory markers. The...
Insmed Jumps on ‘Blowout’ Sales Beat for Bronchiectasis Drug Brinsupri
Insmed reported that its newly approved bronchiectasis therapy Brinsupri generated $144.6 million in Q4 2025 sales, nearly three times analyst forecasts. The surge was driven by roughly 9,000 new patients, bringing total users to about 11,500 and pushing the stock up 8%....
J&J Strikes Drug Pricing, Tariff Deal with the White House
Johnson & Johnson has become the latest pharmaceutical company to sign a "most‑favored‑nation" pricing agreement with the White House. The deal commits J&J to lower the list prices of a portfolio of high‑cost drugs for federal programs, including Medicare and...
Roche Spends $570M on Another ADC Agreement With China’s MediLink
Roche has agreed to pay $570 million in upfront and near‑term milestone fees to secure exclusive worldwide rights—except mainland China, Hong Kong and Macau—to MediLink’s B7H3‑targeted antibody‑drug conjugate YL201. The ADC, which carries a camptothecin‑derived cytotoxin, is advancing in registrational studies for...
J&J Jumps on the MFN Pricing Train
Johnson & Johnson has become the latest pharmaceutical company to sign a Most‑Favoured Nation (MFN) drug‑pricing agreement with the Trump administration, securing an exemption from looming tariffs. The deal, the 15th of its kind, will make J&J medicines available through...
Rampart Closes Down Less Than 2 Years After Launch
Rampart Bioscience, a stealth startup that raised $85 million in a Series A round to develop a non‑viral DNA‑based therapy platform called HALO, has shut down less than two years after emerging from stealth. The company’s website and LinkedIn page have been...
The 4x Rule: Why some People’s DNA Is More Unstable than Others
Researchers analyzed nearly one million genomes and found that short DNA repeats steadily lengthen with age. Inherited genetic variants can accelerate or decelerate this expansion by up to four‑fold, creating substantial individual differences. The study uncovered a previously unknown repeat...
InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot
InflaRx announced a restructuring that will eliminate roughly 30% of its workforce and incur about $7 million in one‑time, largely non‑cash, costs. The company is pulling funding from its COVID‑19 antibody Gohibic and redirecting resources toward izicopan, an oral C5a‑receptor inhibitor...
Roche Returns to Chinese Biotech MediLink for Another ADC Pact
Roche has entered a second licensing agreement with Chinese biotech MediLink, this time to develop an antibody‑drug conjugate (ADC) that targets the B7‑H3 antigen on solid tumours. The deal builds on a prior partnership focused on earlier‑stage oncology assets and...
AirNexis Gets $200M to Test China-Derived COPD Drug
AirNexis, a Palo Alto biotech, announced a $200 million financing round to launch clinical testing of a chronic obstructive pulmonary disease (COPD) therapy derived from Chinese research. The capital, sourced from a mix of U.S. and Chinese investors, will fund Phase 2/3...
Cellares and City of Hope Sign Deal to Automate Solid Tumor CAR T Cell Therapy Manufacturing
Biotech firm Cellares and cancer research center City of Hope have entered a partnership to evaluate Cellares’ automated Cell Shuttle manufacturing platform and Cell Q quality‑control system for City of Hope’s investigational CARpool IL13RA2‑EGFR CAR‑T therapy targeting glioblastoma multiforme. The...
Speculation Builds About a Deal for Revolution Medicines
Speculation is mounting that Revolution Medicines, a mid‑stage biotech focused on precision oncology, is in advanced talks with one or more large pharmaceutical companies. Media outlets report that the discussions could lead to a takeover or strategic partnership, though no...
Enliven’s Phase 1 Leukemia Pill Data Look Competitive with Novartis and Terns
Enliven Therapeutics announced Phase 1 results for its oral leukemia candidate, showing response rates and safety comparable to leading therapies from Novartis and Terns. The data revealed a 45% overall remission rate and manageable adverse events across 30 patients. The...
Viking Gets Commercial Chief While Other Obesity Biotechs Sell; Novo's Uli Stilz Steps Down
Viking Therapeutics announced the appointment of Neil Aubuchon as its chief commercial officer, signaling a push to accelerate commercialization of its obesity and MASH drug candidates. The move comes as the company’s shareholders grow impatient for a strategic partner or...
Evaluating Sarcopenia Criteria for Fall Prediction in Seniors
A recent cohort study examined multiple sarcopenia diagnostic criteria to determine which best predicts falls among seniors aged 65 and older. Researchers compared the European Working Group on Sarcopenia in Older People (EWGSOP2) algorithm, the SARC‑F questionnaire, and simple performance...
Mapping Prenatal Microbial Diversity in Amniotic Fluid
A new study has produced the first comprehensive map of microbial diversity in amniotic fluid, challenging the long‑held belief that the intrauterine environment is sterile. Researchers analyzed over 500 samples using ultra‑sensitive metagenomic sequencing, identifying a low‑biomass but distinct bacterial...
Gene Editing Pioneers Launch First Startup Focused on Custom CRISPR Therapies
A team of leading gene‑editing scientists has launched a new startup dedicated to developing custom CRISPR therapies for individual patients. The company builds on a landmark case last spring where researchers engineered a bespoke CRISPR treatment to correct a rare...
A New CRISPR Startup Is Betting Regulators Will Ease up on Gene-Editing
A new CRISPR startup, Aurora Therapeutics, aims to secure regulatory approval for a single, modular gene‑editing platform that can be tweaked for multiple mutations. Backed by $16 million from Menlo Ventures and advised by CRISPR co‑inventor Jennifer Doudna, Aurora’s first target...
Report Says MSD Is in Talks to Buy Revolution Meds
Financial Times reports MSD is in advanced talks to acquire Revolution Medicines in a deal valued between $28 billion and $32 billion, potentially the largest pharma merger since Pfizer's Seagen purchase. The announcement sent Revolution’s shares up 16% in pre‑market trading, giving...
Study Finds Food Waste Compost Less Effective than Potting Mix Alone
Researchers at the University of Arkansas evaluated food‑waste compost as a growing substrate for tomato and watermelon seedlings. The study, published in HortTechnology, found that pure food‑waste compost performed worse than standard peat‑based potting mix, while blends containing less than...
Bone Marrow Immune Cell Map Boosts Survival, Relapse Prediction in Multiple Myeloma
Researchers created a single‑cell immune atlas of bone‑marrow cells from 337 newly diagnosed multiple myeloma patients, profiling nearly 1.4 million plasma and immune cells. The study, published in Nature Cancer, links specific immune cell populations and signaling pathways to rapid relapse...
New Single‑Cell Testing Measures How Effectively Antibiotics Kill Bacteria
Researchers at the University of Basel introduced Antimicrobial Single‑Cell Testing (ASCT), a high‑throughput live‑cell imaging platform that quantifies antibiotic killing at single‑cell resolution. By dispensing bacteria into 1,536‑well plates and tracking up to one million images per experiment, the team...
M Ventures: Pharma CVC and Biotech Innovation in 2026
Merck KGaA’s corporate venture arm, M Ventures, opened 2026 with Managing Director Hakan Goker outlining its 2025 successes and 2026 priorities. The CVC highlighted marquee investments such as FoRx Therapeutics and Artios, which earned an FDA Fast Track designation, and...
Higher Consumption of Food Preservatives Is Associated with an Increased Risk of Type 2 Diabetes
Researchers from Inserm and partner institutions analyzed data from over 100,000 French adults in the NutriNet‑Santé cohort and found that higher consumption of food preservatives—both non‑antioxidant and antioxidant types—was linked to a 40‑49% increased incidence of type 2 diabetes. The study...
R-Loops Drive RNAPII Reprogramming in Early Development
A new study reveals that R‑loops, three‑strand nucleic‑acid structures, actively reprogram RNA polymerase II (RNAPII) positioning during early embryonic development. Genome‑wide mapping in mouse zygotes shows that 30% of RNAPII peaks coincide with R‑loop sites, directing transcription toward lineage‑specific genes....
Youth Sarcopenia and Body Composition via Bioimpedance
A new study published on Bioengineer.org reveals that bioimpedance analysis (BIA) can reliably detect sarcopenia and altered body composition in adolescents. Researchers evaluated over 1,200 youths aged 12‑19, finding a 7.4% prevalence of low muscle mass that exceeds prior estimates...
CircRNA14781 Drives Olaparib Resistance in Ovarian Cancer
Researchers identified circular RNA circRNA14781 as a key driver of olaparib resistance in high‑grade ovarian cancer. The non‑coding RNA is markedly overexpressed in tumor samples that fail PARP‑inhibitor therapy and functions by sponging tumor‑suppressive microRNAs, thereby re‑activating DNA‑repair pathways. In...
Mapping Eucalyptus Genes for Phosphate Transport Efficiency
Researchers have completed a high‑resolution map of eucalyptus genes that control phosphate transport, pinpointing dozens of candidate transporters. Expression profiling shows several genes surge when trees face low‑phosphate soils, suggesting natural efficiency mechanisms. The team demonstrated CRISPR‑mediated edits that boost...
Chlorella Nanogels Suppress Lung Injury Inflammation
Researchers have engineered chlorella‑derived nanogels that markedly suppress inflammation in experimental lung injury. In murine models, the nanogels lowered pro‑inflammatory cytokines, reduced alveolar edema, and improved survival rates. The delivery platform leverages the natural biocompatibility of chlorella polysaccharides to target...
2025 FDA Approvals: Innovation Holds Steady in First Year Under New Leadership
Under the FDA’s new leadership, 2025 saw the approval of 46 new molecular entities and 10 new biologics, matching the pace of recent years. The agency’s review process remained on schedule, suggesting that the transition in senior management has not...
Albendazole’s Impact on Helminths in Yunnan Kids
Researchers evaluated a school‑based albendazole deworming program among 3,200 children aged 5‑12 in Yunnan province. Baseline surveys showed a 42% helminth infection rate, which fell to 13% after a single annual dose. The intervention also correlated with modest gains in...
OpenAI Brings ChatGPT to Hospitals on the Heels of Launching Consumer Health Tool
OpenAI unveiled ChatGPT for Healthcare, extending its popular conversational AI into hospitals and health systems. The offering follows the recent launch of a consumer‑focused health tool, signaling a broader push into clinical environments. OpenAI says the service will integrate with...
Expert Consensus on Validating Internal Jugular Ultrasound Tool
A panel of leading emergency physicians, intensivists, and radiologists released an expert consensus outlining a structured validation pathway for internal jugular vein ultrasound (IJU) tools. The framework delineates three validation phases—technical performance, operator reproducibility, and clinical outcome impact—backed by specific...
Evaluating Acupuncture for Cancer Treatment Fatigue: A Review
A recent systematic review examined acupuncture as a therapeutic option for cancer‑related fatigue, analyzing data from 18 randomized controlled trials involving over 2,000 patients. The analysis found that acupuncture produced modest but statistically significant reductions in fatigue severity compared with...
New Framework Enhances Climate Health Vulnerability Analysis
A multidisciplinary research team has unveiled a new analytical framework that fuses high‑resolution climate data with population health metrics to assess climate‑related health vulnerability. The platform leverages machine‑learning‑driven spatial modeling, incorporating temperature, air‑quality, and socioeconomic indicators to predict disease risk...
Microbial Communities and Tight Junctions in Cattle’s Gut
A new study links specific microbial communities to the integrity of tight junction proteins in the bovine gut, showing that a higher abundance of *Ruminococcus* and *Lactobacillus* correlates with stronger barrier function. Metagenomic sequencing and intestinal tissue analysis revealed a...
Deformable Adjuvants Can Enhance Immune Activation in New Vaccine Design
Researchers at the Chinese Academy of Sciences have engineered aluminum‑stabilized Pickering emulsions (ASPE) that act as deformable adjuvants, providing mechanical cues to dendritic cells. By adjusting nanoparticle crystallinity, the interfacial stiffness can be tuned to activate the mechanosensitive PIEZO1 channel,...
Aberrant Calcium Signaling and Neuronal Activity in the L271H CACNA1D (Cav1.3) iPSC Model of Neurodevelopmental Disease
Researchers created the first patient‑derived iPSC model carrying the de novo L271H CACNA1D (Ca_v1.3) variant linked to neurodevelopmental disease. The study shows that Ca_v1.3 is the dominant L‑type calcium channel in neural progenitor cells, where the mutation drives heightened spontaneous calcium...
TIGIT Disruption Boosts Low-Avidity T Cell Tumor Attack
Researchers have demonstrated that genetic disruption of the inhibitory receptor TIGIT markedly amplifies the anti‑tumor activity of low‑avidity T cells. In mouse models, TIGIT‑deficient T cells infiltrated tumors more efficiently and induced significant tumor regression, especially when paired with existing...
WRKY Gene Family’s Role in Cucurbita Moschata Resistance
Researchers have identified specific WRKY transcription factors that enhance disease resistance in Cucurbita moschata, commonly known as winter squash. Using genome‑wide association studies and CRISPR‑mediated knock‑outs, the team pinpointed WRKY45 and WRKY70 as key regulators against Phytophthora blight. Field trials...
Noncanonical TRPM4 Controls Intestinal Fluid Balance
Researchers have identified a noncanonical isoform of the TRPM4 ion channel that directly regulates intestinal fluid secretion and absorption. Using mouse models and human intestinal organoids, the study showed that loss of this isoform leads to dysregulated electrolyte transport and...
METTL3 Loss Drives Glioma via Macrophage Lipids
Researchers have discovered that loss of the RNA methyltransferase METTL3 accelerates glioma progression by reprogramming macrophage lipid metabolism. The study shows METTL3‑deficient tumor cells induce lipid accumulation in tumor‑associated macrophages, creating an immunosuppressive microenvironment that fuels tumor growth. Mechanistic analysis...
Designing Liver Simulants with Hyperelastic Micromechanics
On January 9, 2026 Bioengineer.org published a suite of research highlights spanning nanomedicine, parasitology, medical imaging, climate‑health analytics, and plant genetics. The pieces report that chlorella‑based nanogels markedly suppress lung injury inflammation, albendazole effectively reduces helminth burdens in Yunnan children, and an...
Sanofi Calls Rejection of Potential MS Blockbuster 'Unexpected'
Sanofi announced that the FDA rejected its experimental multiple‑sclerosis therapy, labeling the decision unexpected. The agency raised substantive questions late in the review process, leaving insufficient time for Sanofi to amend its submission. The setback threatens the anticipated launch of...
Illumina Hires Eric Green as Chief Medical Officer
Illumina announced the appointment of Eric Green, former director of the National Human Genome Research Institute and a pioneering geneticist, as its new chief medical officer. Green will lead the company’s clinical strategy, regulatory affairs, and diagnostic product development. The...
How Light Reflects on Leaves May Help Researchers Identify Dying Forests
Researchers at the University of Notre Dame have demonstrated that leaf spectral reflectance measured from airborne or satellite sensors can predict the expression of key stress‑related genes. By sampling sugar maple and red maple leaves in Wisconsin and Michigan, they...
